MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 129 filers reported holding MACROGENICS INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,059,869 | -12.9% | 1,300,401 | +0.0% | 0.00% | – |
| Q2 2023 | $6,956,610 | -25.6% | 1,300,301 | -0.2% | 0.00% | -100.0% |
| Q1 2023 | $9,344,417 | -46.1% | 1,303,266 | -49.5% | 0.00% | 0.0% |
| Q4 2022 | $17,330,762 | +263.7% | 2,582,826 | +87.5% | 0.00% | – |
| Q3 2022 | $4,765,000 | +27.3% | 1,377,304 | +8.6% | 0.00% | – |
| Q2 2022 | $3,742,000 | -88.0% | 1,268,554 | -64.2% | 0.00% | -100.0% |
| Q1 2022 | $31,229,000 | -33.2% | 3,544,724 | +21.7% | 0.00% | 0.0% |
| Q4 2021 | $46,748,000 | -24.1% | 2,912,670 | -1.0% | 0.00% | -33.3% |
| Q3 2021 | $61,622,000 | -29.0% | 2,942,781 | -8.9% | 0.00% | -40.0% |
| Q2 2021 | $86,800,000 | +2.1% | 3,231,559 | +21.1% | 0.01% | 0.0% |
| Q1 2021 | $85,013,000 | +44.3% | 2,669,170 | +3.6% | 0.01% | +25.0% |
| Q4 2020 | $58,919,000 | +1.3% | 2,577,363 | +11.6% | 0.00% | 0.0% |
| Q3 2020 | $58,181,000 | +32.8% | 2,309,668 | +47.2% | 0.00% | +33.3% |
| Q2 2020 | $43,814,000 | +293.0% | 1,569,280 | -18.1% | 0.00% | +200.0% |
| Q1 2020 | $11,150,000 | -46.9% | 1,915,848 | -0.8% | 0.00% | 0.0% |
| Q4 2019 | $21,005,000 | -12.7% | 1,930,610 | +2.3% | 0.00% | -50.0% |
| Q3 2019 | $24,073,000 | -45.9% | 1,886,618 | -28.1% | 0.00% | -33.3% |
| Q2 2019 | $44,527,000 | +73.9% | 2,623,875 | +84.3% | 0.00% | +50.0% |
| Q1 2019 | $25,598,000 | +49.8% | 1,423,718 | +5.8% | 0.00% | 0.0% |
| Q4 2018 | $17,088,000 | -35.7% | 1,345,529 | +8.6% | 0.00% | 0.0% |
| Q3 2018 | $26,564,000 | -15.2% | 1,239,115 | -18.3% | 0.00% | -33.3% |
| Q2 2018 | $31,325,000 | +19.6% | 1,517,112 | +45.8% | 0.00% | +50.0% |
| Q1 2018 | $26,188,000 | +31.8% | 1,040,602 | -0.5% | 0.00% | 0.0% |
| Q4 2017 | $19,871,000 | +7.1% | 1,045,936 | +4.2% | 0.00% | 0.0% |
| Q3 2017 | $18,561,000 | +9.3% | 1,004,217 | +3.6% | 0.00% | 0.0% |
| Q2 2017 | $16,974,000 | -9.4% | 969,221 | -3.8% | 0.00% | 0.0% |
| Q1 2017 | $18,732,000 | +9.2% | 1,007,211 | +20.0% | 0.00% | 0.0% |
| Q4 2016 | $17,152,000 | -31.0% | 839,491 | +1.0% | 0.00% | -33.3% |
| Q3 2016 | $24,852,000 | +28.7% | 830,830 | +16.1% | 0.00% | +50.0% |
| Q2 2016 | $19,309,000 | +27.1% | 715,507 | -11.6% | 0.00% | 0.0% |
| Q1 2016 | $15,189,000 | -36.8% | 809,705 | +4.3% | 0.00% | -33.3% |
| Q4 2015 | $24,048,000 | -23.0% | 776,396 | -46.7% | 0.00% | -25.0% |
| Q3 2015 | $31,218,000 | -31.6% | 1,457,609 | +21.2% | 0.00% | -20.0% |
| Q2 2015 | $45,655,000 | +50.4% | 1,202,329 | +24.3% | 0.01% | +66.7% |
| Q1 2015 | $30,346,000 | +180.2% | 967,366 | +213.4% | 0.00% | +200.0% |
| Q4 2014 | $10,832,000 | +85.6% | 308,709 | +10.6% | 0.00% | 0.0% |
| Q3 2014 | $5,835,000 | -4.8% | 279,206 | -1.0% | 0.00% | 0.0% |
| Q2 2014 | $6,132,000 | +130.1% | 282,122 | +194.6% | 0.00% | – |
| Q1 2014 | $2,665,000 | +24.8% | 95,749 | +22.9% | 0.00% | – |
| Q4 2013 | $2,135,000 | – | 77,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |